Share-based Payment Arrangement, Expense of VIEMED HEALTHCARE, INC. from 31 Mar 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
VIEMED HEALTHCARE, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2018 to 31 Dec 2025.
  • VIEMED HEALTHCARE, INC. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $2,300,000, a 51% increase year-over-year.
  • VIEMED HEALTHCARE, INC. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $9,132,000, a 45% increase year-over-year.
  • VIEMED HEALTHCARE, INC. annual Share-based Payment Arrangement, Expense for 2025 was $9,132,000, a 45% increase from 2024.
  • VIEMED HEALTHCARE, INC. annual Share-based Payment Arrangement, Expense for 2024 was $6,285,000, a 7.5% increase from 2023.
  • VIEMED HEALTHCARE, INC. annual Share-based Payment Arrangement, Expense for 2023 was $5,849,000, a 12% increase from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

VIEMED HEALTHCARE, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $9,132,000 $2,300,000 +$779,000 +51% 01 Oct 2025 31 Dec 2025 10-K 04 Mar 2026 2025 FY
Q3 2025 $8,353,000 $2,180,000 +$468,000 +27% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $7,885,000 $2,341,000 +$721,000 +45% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $7,164,000 $2,311,000 +$879,000 +61% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $6,285,000 $1,521,000 -$13,000 -0.85% 01 Oct 2024 31 Dec 2024 10-K 04 Mar 2026 2025 FY
Q3 2024 $6,298,000 $1,712,000 +$259,000 +18% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $6,039,000 $1,620,000 +$149,000 +10% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $5,890,000 $1,432,000 +$41,000 +2.9% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 $5,849,000 $1,534,000 +$217,000 +16% 01 Oct 2023 31 Dec 2023 10-K 04 Mar 2026 2025 FY
Q3 2023 $5,632,000 $1,453,000 +$144,000 +11% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $5,488,000 $1,471,000 +$200,000 +16% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $5,288,000 $1,391,000 +$86,000 +6.6% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024 2024 Q1
Q4 2022 $5,202,000 $1,317,000 +$12,000 +0.92% 01 Oct 2022 31 Dec 2022 10-K 10 Mar 2025 2024 FY
Q3 2022 $5,190,000 $1,309,000 +$7,000 +0.54% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023 2023 Q3
Q2 2022 $5,183,000 $1,271,000 +$35,000 +2.8% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $5,148,000 $1,305,000 -$2,000 -0.15% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q4 2021 $5,150,000 $1,305,000 +$4,000 +0.31% 01 Oct 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 $5,146,000 $1,302,000 +$68,000 +5.5% 01 Jul 2021 30 Sep 2021 10-Q 01 Nov 2022 2022 Q3
Q2 2021 $5,078,000 $1,236,000 +$40,000 +3.3% 01 Apr 2021 30 Jun 2021 10-Q 02 Aug 2022 2022 Q2
Q1 2021 $5,038,000 $1,307,000 +$156,000 +14% 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022 2022 Q1
Q4 2020 $4,882,000 $1,301,000 +$393,000 +43% 01 Oct 2020 31 Dec 2020 10-K 07 Mar 2022 2021 FY
Q3 2020 $4,489,000 $1,234,000 +$170,000 +16% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021 2021 Q3
Q2 2020 $4,319,000 $1,196,000 +$162,000 +16% 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021 2021 Q2
Q1 2020 $4,157,000 $1,151,000 +$271,000 +31% 01 Jan 2020 31 Mar 2020 10-Q 03 May 2021 2021 Q1
Q4 2019 $3,886,000 $908,000 +$104,000 +13% 01 Oct 2019 31 Dec 2019 10-K 03 Mar 2021 2020 FY
Q3 2019 $3,782,000 $1,064,000 +$392,000 +58% 01 Jul 2019 30 Sep 2019 10-Q 04 Nov 2020 2020 Q3
Q2 2019 $3,390,000 $1,034,000 +$369,000 +55% 01 Apr 2019 30 Jun 2019 10-Q 04 Aug 2020 2020 Q2
Q1 2019 $3,021,000 $880,000 +$319,000 +57% 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020 2020 Q1
Q4 2018 $2,702,000 $804,000 01 Oct 2018 31 Dec 2018 10-K 04 Mar 2020 2019 FY
Q3 2018 $672,000 01 Jul 2018 30 Sep 2018 10-K 04 Mar 2020 2019 FY
Q2 2018 $665,000 01 Apr 2018 30 Jun 2018 10-K 04 Mar 2020 2019 FY
Q1 2018 $561,000 01 Jan 2018 31 Mar 2018 10-K 04 Mar 2020 2019 FY

VIEMED HEALTHCARE, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $9,132,000 +$2,847,000 +45% 01 Jan 2025 31 Dec 2025 10-K 04 Mar 2026 2025 FY
2024 $6,285,000 +$436,000 +7.5% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2026 2025 FY
2023 $5,849,000 +$647,000 +12% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2026 2025 FY
2022 $5,202,000 +$52,000 +1% 01 Jan 2022 31 Dec 2022 10-K 10 Mar 2025 2024 FY
2021 $5,150,000 +$268,000 +5.5% 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
2020 $4,882,000 +$996,000 +26% 01 Jan 2020 31 Dec 2020 10-K 07 Mar 2022 2021 FY
2019 $3,886,000 +$1,184,000 +44% 01 Jan 2019 31 Dec 2019 10-K 03 Mar 2021 2020 FY
2018 $2,702,000 01 Jan 2018 31 Dec 2018 10-K 04 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.